As shown in Fig. 5A, tumor-bearing animals treated with pE7+pIL-2+anti-4-1BB Abs displayed significantly lower Ag-specific IgG responses compared to animals treated with pE7+pIL-2+control Abs or pE7 alone. Here, TNFRSF9 is linked to neoplasm.